Related Experiment Video

Updated: Feb 26, 2026

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

20.3K

Dysregulated immune microenvironment in metastatic colorectal cancer

Shuaixing An1,2, Zhaojin Yu1,3,4, Jianping Li5,6,7

  • 1Department of Pharmacology, School of Pharmacy, China Medical University, No.77, Puhe Road, Shenyang North New Area, Shenyang, 110122, Liaoning Province, P. R. China.

Medical Oncology (Northwood, London, England)
|February 24, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
BiomarkerCancer immune microenvironmentEpigeneticImmune landscapeImmunotherapyMetastatic colorectal cancerMutationProteomic

More Related Videos

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

10.0K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

8.2K

Related Experiment Videos

Last Updated: Feb 26, 2026

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

20.3K
The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

10.0K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

8.2K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Metastasis02:30

Metastasis

6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K

Articles linked to this work by shared authors, journal, and citation graph.

Rebuilding soil organic C stocks in degraded grassland by grazing exclusion: a linked decline in soil inorganic C.

PeerJ·2020

[Management of COVID-19: the Zhejiang experience].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences·2020

Hypoxia/reoxygenation activates the JNK pathway and accelerates synovial senescence.

Molecular medicine reports·2020

Tetrahydroxy stilbene glycoside alleviated inflammatory damage by mitophagy via AMPK related PINK1/Parkin signaling pathway.

Biochemical pharmacology·2020

Association between plasma retinol levels and the risk of all-cause mortality in general hypertensive patients: A nested case-control study.

Journal of clinical hypertension (Greenwich, Conn.)·2020

Brachial-Ankle Pulse Wave Velocity Predicts New-Onset Hypertension and the Modifying Effect of Blood Pressure in a Chinese Community-Based Population.

International journal of hypertension·2020

Metabolomics-guided network pharmacology and molecular modeling suggest bioactive components of Chiliadenus montanus associated with multi-target anticancer and anti-inflammatory activities.

Medical oncology (Northwood, London, England)·2026

Homeobox genes in endocrine tumorigenesis: mechanisms, tumor microenvironment interaction, and therapeutic potential.

Medical oncology (Northwood, London, England)·2026

Mechanism of neoantigen generation and advances in neoantigen-based immunotherapies in colorectal cancer.

Medical oncology (Northwood, London, England)·2026

Synthetic and mechanistic outlines of magnetoelectric nanomedicine for targeted cancer therapy.

Medical oncology (Northwood, London, England)·2026

Feasibility and safety of accelerated MVAC (aMVAC) in geriatric patients with muscle-invasive bladder cancer.

Medical oncology (Northwood, London, England)·2026

KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms.

Medical oncology (Northwood, London, England)·2026

Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.

JTO clinical and research reports·2026

Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis.

Urologic oncology·2026

Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

B-cells in breast cancer: current insights and challenges.

Frontiers in oncology·2026

Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions.

Frontiers in oncology·2026

The heterogeneous and dynamic immune-tumor interface in breast cancer.

Frontiers in oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us